The stock price didn't jump after ONEOK, Inc. (NYSE:OKE) posted decent earnings last week. We think that investors might be worried about some concerning underlying factors. Trump has pledged to ...

A lackluster earnings announcement from Chin Hin Group Berhad (KLSE:CHINHIN) last week didn't sink the stock price. We think that investors are worried about some weaknesses underlying the earnings.

On May 9, 2025, Semiconductor Manufacturing International Corporation (SMIC) held its first quarter 2025 earnings call, with co-CEO Haijun Zhao addressing performance, tariff impacts, and ...

Although Nvidia Corp.’s and Broadcom Inc.’s earnings reports are still weeks away, some analysts are already comforted by Big Tech’s eagerness to continue spending billions of dollars on ...

Sempra Energy reported first-quarter operating earnings per share of $1.44, up from $1.34 in the same year-ago period, putting the company on track and to meet our and management's expectations ...

Zacks Small Cap also issued estimates for Titan International’s Q4 2025 earnings at ($0.01) EPS, FY2025 earnings at $0.05 EPS and FY2026 earnings at $0.45 EPS. Get Titan International alerts: ...

The market wasn't impressed with the soft earnings from EPB Group Berhad (KLSE:EPB) recently. We did some further digging and think they have a few more reasons to be concerned beyond the statutory ...

Coralogix, a cross-stack observability platform provider, is introducing Continuous Profiling, an advanced capability that delivers real-time visibility into application performance without any code ...

HNI Corporation exceeded analyst expectations for the first quarter of 2025, reporting an earnings per share (EPS) of $0.44, surpassing the forecasted $0.35. Revenue also outperformed projections ...

A lackluster earnings announcement from Thomson Reuters Corporation (TSE:TRI) last week didn't sink the stock price. However, we believe that investors should be aware of some underlying factors which ...

primarily due to inventory challenges and funding issues with co-pay assistance programs. The biopharmaceutical company posted adjusted earnings per share of -$0.74, missing the analyst consensus ...